Antiplatelets And Anticoagulants Flashcards

1
Q

In absence of vascular injury, these keep platelets from aggregating released by endothelium

A

NO - dilates blood vessel

Prostacyclin - binds to platelet receptors to prevent aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Platelets adhere to exposed collagen via

A

von Willebrand Factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Activated irregularly shaped platelets secrete granules that attract and activate even more platelets to site of injury

A
Platelet activating factor
ADP
Thrombin 
TXA2
Serotonin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Platelet receptor that binds to circulating fibrinogen

Fibrinogen binds to two separate platelets that form aggregates

A

GPIIb/IIIa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Platelet activation leads to formation of TXA2 from activation of arachidonic acid by COX -> PGH2 -> TXA2

Irreversibly inactivates COX1 enzyme thus effectively disruptiong clot formation

A

Aspirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Blocks action of the ADP receptor P2Y12 subtype on PLATELET

Prevents binding of ADP to P2Y12 receptor leading to inactivation of GPIIb/IIIa receptors that bind to fibrinogen to promote cross-linking

A

ADP P2Y12 inhibitors

Clopidogrel
Prasugrel
Ticagrelor
Ticlodipine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Blocks GPIIb/IIIa receptors on PLATELET so it will not bind to fibrinogen and will not cross link

Administered only IV

A

Abciximab
Eptifibatide
Tirofiban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Phosphodiesterase inhibitors responsible for breaking down cyclic AMP to AMP

Blocking phosphodiesterase
INC intracellular levels of cAMP
DEC intracellular Calcium
Inhibition of platelet activation

A

PDE inhibitors

Dipyridamole
Cilostazol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Also inhibits PDE in the vascular wall and
Inhibits uptake of adenosine leading to VASODILATION

Hence used for PAD (narrowing of vessel)

A

Cilostazol

SE: headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Antiplatelets

A

Aspirin
ADP P2Y12 inhibitors (Clopid, Prasu, Ticlodipine, Ticagrelor)
GPIIb/IIIa inhibitors (Abciximab, Eptifibatide, Tirofiban)
PDE inhibitors (Cilostazol, Dipyridamole)

SE: bleeding, headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Binds to Anti thrombin III to inactivate Factor Xa and Thrombin

Accelerates Anti thrombin III

A

Heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Selectively accelerate inactivation of Factor Xa

A

Low molecular weight heparin

Enoxaparin
Dalterparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

No direct effect on thrombin

Selectively binds to Anti thrombin III thereby inhibiting factor Xa ONLY

Related to LMWH

A

Fondaparinux

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Binding to heparin or LMWH to form stable inactive complex

Reverses excessive bleeding caused by heparin drugs

A

Protamine sulfate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Heparin SE

Antibodies made against heparin when it is bound to platelet derived protein called Platelet Factor-4

Platelets clump together form unwanted clots

A

Heparin-induced thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Direct inhibitors of Factor Xa

Bind directly to active site of Factor Xa preventing it from converting

Prothrombin -> Thrombin

Oral

A

Apixaban

Rivaroxaban

17
Q

Direct thrombin inhibitors

A

Univalent direct thrombin inhibitors (bind only to active site)
Bivalent Direct thrombin inhibitors (both active site and exosite-1 fibrinogen binding site)

18
Q

Univalent Direct Antithrombin drugs

A

Argatobran

Dabigatran

19
Q

Bivalent direct antithrombin

A

Bivalirudin

Desirudin

20
Q

Direct antithrombin inhibitors are useful in treatment of heparin induced thrombocytopenia because they do not bind to

A

PA F4

21
Q

Decreases Vitamin K that carboxylases Factors 1972

Inhibits Vitamin K epoxide reductase disrupting Vitamin K dependent synthesis of coagulating factors

Narrow therapeutic windows
Many drug-drug interactions

Monitor with PT and INR

A

Warfarin

22
Q

Overcomes Warfarin induced bleeding but takes 24 hours

A

Vitamin K

If emergency transfuse FFP

23
Q

Act on existing clot causing it to dissolve by activating Plasminogen turning them into plasmin

Plasmin is the enzyme that breaks fibrin molecules dissolving clot

SELECTIVE to FIBRIN BOUND PLASMINOGEN, CLOT SELECTIVE DISSOLVES FIBRIN IN THROMBUS

Developed by DNA recombinant technology to mimic TPA

A

Alteplase
Reteplase
Tenecteplase

24
Q

Thrombolytic produced from culture human kidney cell

Less clot selective and are more likely to cause internal bleeding into any organ system

A

Urokinase

25
Q

Thrombolytic from streptococcal bacteria

Less clot selective and are more likely to cause internal bleeding into any organ system

A

Streptokinase

26
Q

Antidote to thrombolytic bleeding

Inhibits plasminogen so plasmin will inactivate fibrinolysis

A

Aminocaproic acid

Tranexamic acid